Hypertension-misattributed kidney disease in African Americans

Kidney International

Volumn 83, Issue 1, 2013, Pages 6-9

  Skorecki, Karl L ^a   Wasser, Walter G ^b  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b Rambam Health Care Campus ^*  (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PROTEIN;

AFRICA; AFRICAN AMERICAN; ALLELE; APOL1 GENE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CASE CONTROL STUDY; CHROMOSOME 22Q; CHRONIC KIDNEY DISEASE; CREATININE URINE LEVEL; DIAGNOSTIC ERROR; DISEASE ASSOCIATION; DNA DETERMINATION; DNA SEQUENCE; ENVIRONMENTAL FACTOR; EVOLUTIONARY ADAPTATION; FOCAL GLOMERULOSCLEROSIS; GENE; GENE ACTIVITY; GENE FREQUENCY; GENE INTERACTION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC EPIDEMIOLOGY; GENETIC RISK; GENETIC TRANSFORMATION; GENETIC VARIABILITY; GENOTYPE; GEOGRAPHIC DISTRIBUTION; GLOMERULUS FILTRATION RATE; GRAFT SURVIVAL; HIV ASSOCIATED NEPHROPATHY; HUMAN; HYPERTENSION; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY GRAFT; MOLECULAR EPIDEMIOLOGY; MYH9 GENE; PATHOGENESIS; PHENOTYPE; POPULATION GENETICS; PRIORITY JOURNAL; PROFESSIONAL STANDARD; PROTEIN URINE LEVEL; PROTEINURIA; RENAL REPLACEMENT THERAPY; RENOVASCULAR HYPERTENSION; REVIEW; RISK ASSESSMENT; SURVIVAL FACTOR; TRYPANOSOMA RHODESIENSE;

EID: 84871738290     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2012.369     Document Type: Note

References (15)

1. Appel LJ, Wright JT Jr., Greene T et al. Intensive blood-pressure control in hypertensive chronic kidney disease N Engl J Med 2010; 363: 918-929.
2. Klag MJ, Whelton PK, Randall BL et al. Blood pressure and end-stage renal disease in men. N Engl J Med 1996; 334: 13-18.
3. Marcantoni C, Ma LJ, Federspiel C et al. Hypertensive nephrosclerosis in African Americans versus Caucasians. Kidney Int 2002; 62: 172-180.
4. Lipkowitz MS, Freedman BI, Langefeld CD et al. Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans. Kidney Int 2013; 83: 114-120.
5. Genovese G, Friedman DJ, Ross MD et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 2010; 329: 841-845.
6. Tzur S, Rosset S, Shemer R et al. Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene. Hum Genet 2010; 128: 345-350.
7. Rosset S, Tzur S, Behar DM et al. The population genetics of chronic kidney disease: insights from the MYH9-APOL1 locus. Nat Rev Nephrol 2011; 7: 313-326.
8. Kanji Z, Powe CE, Wenger JB et al. Genetic variation in APOL1 associates with younger age at hemodialysis initiation. J Am Soc Nephrol 2011; 22: 2091-2097.
9. Kopp JB, Nelson GW, Sampath K et al. APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol 2011; 22: 2129-2137.
10. Tzur S, Rosset S, Skorecki K et al. APOL1 Allelic Variants are associated with Lower Age of Dialysis Initiation, and thereby Increased Dialysis Vintage in African and Hispanic Americans with Non-diabetic End Stage Kidney Disease. Nephrol Dial Transplant 2012; 27: 1498-1505.
11. US Renal Data System. 2012 USRDS Annual Data Report: Atlas of End-Stage Renal Disease in the United States. National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health: Bethesda, MD, USA. http://www.usrds.org/2012/pdf/v2-condensed-ref-tables-12.pdf 2012.
12. Reeves-Daniel AM, DePalma JA, Bleyer AJ et al. The APOL1 gene and allograft survival after kidney transplantation. Am J Transplant 2011; 11: 1025-1030.
13. Tobe SW, Poirier L, Tremblay G et al. Challenges and scientific considerations in hypertension management reflected in the 2012 recommendations of the Canadian Hypertension Education Program Open Medicine 2012; 6: e127-133.
14. Voight BF, Peloso GM, Orho-Melander M et al. Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet 2012; 380: 572-580.
15. Twagirumukiza M, De Bacquer D, Kips JG et al. Current and projected prevalence of arterial hypertension in sub-Saharan Africa by sex, age and habitat: an estimate from population studies. J Hypertens 2011; 29: 1243-1252.